Company intelligence / Profile preview
Aros Pharma ApS
Copenhagen, Denmarkbciq-biocentury-com.biomarinproxy01.infotrieve.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Completed a Phase 1 clinical trial for PPC-5650 in Irritable Bowel Syndrome investigating the efficacy and safety on sensation and pain during standardized stimulation of the rectosigmoid.
- Therapeutic areas
- GastroenterologyPulmonologyImmunologyNeurologyInfectious Diseases
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Aros Pharma ApS.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aros Pharma ApS.